{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:22:09Z","timestamp":1787163729086,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T00:00:00Z","timestamp":1253145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s10549-009-0535-6","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T11:27:42Z","timestamp":1253100462000},"page":"87-94","source":"Crossref","is-referenced-by-count":17,"title":["A dose- and time-controllable syngeneic animal model of breast cancer microcalcification"],"prefix":"10.1007","volume":"122","author":[{"given":"Fangbing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine P.","family":"Lunsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne T.","family":"Vannah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Lenkinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Frangioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,17]]},"reference":[{"key":"535_CR1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djh257","volume":"96","author":"SA Feig","year":"2004","unstructured":"Feig SA, Sickles EA, Evans WP, Linver MN (2004) Re: changes in breast cancer detection and mammography recall rates after the introduction of a computer-aided detection system. J Natl Cancer Inst 96:1260\u20131261 author reply 1261","journal-title":"J Natl Cancer Inst"},{"key":"535_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10911-005-5400-6","volume":"10","author":"MP Morgan","year":"2005","unstructured":"Morgan MP, Cooke MM, McCarthy GM (2005) Microcalcifications associated with breast cancer: an epiphenomenon or biologically significant feature of selected tumors? J Mammary Gland Biol Neoplasia 10:181\u2013187","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"535_CR3","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2214\/ajr.181.6.1811679","volume":"181","author":"PC Stomper","year":"2003","unstructured":"Stomper PC, Geradts J, Edge SB, Levine EG (2003) Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol 181:1679\u20131684","journal-title":"AJR Am J Roentgenol"},{"key":"535_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMe048117","volume":"351","author":"L Liberman","year":"2004","unstructured":"Liberman L (2004) Breast cancer screening with MRI-what are the data for patients at high risk? N Engl J Med 351:497\u2013500","journal-title":"N Engl J Med"},{"key":"535_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1075-122X.2006.00269.x","volume":"12","author":"WA Berg","year":"2006","unstructured":"Berg WA, Weinberg IN, Narayanan D, Lobrano ME, Ross E, Amodei L, Tafra L, Adler LP, Uddo J, Stein W 3rd et al (2006) High-resolution fluorodeoxyglucose positron emission tomography with compression (\u201cpositron emission mammography\u201d) is highly accurate in depicting primary breast cancer. Breast J 12:309\u2013323","journal-title":"Breast J"},{"key":"535_CR6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1088\/0031-9155\/53\/3\/009","volume":"53","author":"RR Raylman","year":"2008","unstructured":"Raylman RR, Majewski S, Smith MF, Proffitt J, Hammond W, Srinivasan A, McKisson J, Popov V, Weisenberger A, Judy CO et al (2008) The positron emission mammography\/tomography breast imaging and biopsy system (PEM\/PET): design, construction and phantom-based measurements. Phys Med Biol 53:637\u2013653","journal-title":"Phys Med Biol"},{"key":"535_CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11427-009-0078-4","volume":"52","author":"X Wu","year":"2009","unstructured":"Wu X, Xiao H (2009) Progress in the detection of human genome structural variations. Sci China C Life Sci 52:560\u2013567","journal-title":"Sci China C Life Sci"},{"key":"535_CR8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1259\/bjr.73.871.11089459","volume":"73","author":"C Ferranti","year":"2000","unstructured":"Ferranti C, Coopmans de Yoldi G, Biganzoli E, Bergonzi S, Mariani L, Scaperrotta G, Marchesini M (2000) Relationships between age, mammographic features and pathological tumour characteristics in non-palpable breast cancer. Br J Radiol 73:698\u2013705","journal-title":"Br J Radiol"},{"key":"535_CR9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.crad.2006.10.010","volume":"62","author":"AJ Evans","year":"2007","unstructured":"Evans AJ, Kutt E, Record C, Waller M, Bobrow L, Moss S (2007) Radiological and pathological findings of interval cancers in a multi-centre, randomized, controlled trial of mammographic screening in women from age 40\u201341\u00a0years. Clin Radiol 62:348\u2013352","journal-title":"Clin Radiol"},{"key":"535_CR10","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1021\/ja807099s","volume":"130","author":"KR Bhushan","year":"2008","unstructured":"Bhushan KR, Misra P, Liu F, Mathur S, Lenkinski RE, Frangioni JV (2008) Detection of breast cancer microcalcifications using a dual-modality SPECT\/NIR fluorescent probe. J Am Chem Soc 130:17648\u201317649","journal-title":"J Am Chem Soc"},{"key":"535_CR11","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1002\/anie.200701216","volume":"46","author":"KR Bhushan","year":"2007","unstructured":"Bhushan KR, Tanaka E, Frangioni JV (2007) Synthesis of conjugatable bisphosphonates for molecular imaging of large animals. Angew Chem Int Ed Engl 46:7969\u20137971","journal-title":"Angew Chem Int Ed Engl"},{"key":"535_CR12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1076-6332(03)00253-8","volume":"10","author":"RE Lenkinski","year":"2003","unstructured":"Lenkinski RE, Ahmed M, Zaheer A, Frangioni JV, Goldberg SN (2003) Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer. Acad Radiol 10:1159\u20131164","journal-title":"Acad Radiol"},{"key":"535_CR13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nbt1201-1148","volume":"19","author":"A Zaheer","year":"2001","unstructured":"Zaheer A, Lenkinski RE, Mahmood A, Jones AG, Cantley LC, Frangioni JV (2001) In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 19:1148\u20131154","journal-title":"Nat Biotechnol"},{"key":"535_CR14","first-page":"5375","volume":"62","author":"AS Haka","year":"2002","unstructured":"Haka AS, Shafer-Peltier KE, Fitzmaurice M, Crowe J, Dasari RR, Feld MS (2002) Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy. Cancer Res 62:5375\u20135380","journal-title":"Cancer Res"},{"key":"535_CR15","first-page":"175","volume":"7","author":"F Liu","year":"2008","unstructured":"Liu F, Bloch N, Bhushan KR, De Grand AM, Tanaka E, Solazzo S, Mertyna PM, Goldberg N, Frangioni JV, Lenkinski RE (2008) Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification. Mol Imaging 7:175\u2013186","journal-title":"Mol Imaging"},{"key":"535_CR16","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.3201241","volume":"242","author":"JM Wozney","year":"1988","unstructured":"Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528\u20131534","journal-title":"Science"},{"key":"535_CR17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-1656(01)00425-4","volume":"94","author":"LF Vallejo","year":"2002","unstructured":"Vallejo LF, Brokelmann M, Marten S, Trappe S, Cabrera-Crespo J, Hoffmann A, Gross G, Weich HA, Rinas U (2002) Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 94:185\u2013194","journal-title":"J Biotechnol"},{"key":"535_CR18","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1083\/jcb.127.6.1755","volume":"127","author":"T Katagiri","year":"1994","unstructured":"Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755\u20131766","journal-title":"J Cell Biol"},{"key":"535_CR19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2967\/jnumed.107.040303","volume":"48","author":"P Misra","year":"2007","unstructured":"Misra P, Humblet V, Pannier N, Maison W, Frangioni JV (2007) Production of multimeric prostate-specific membrane antigen small-molecule radiotracers using a solid-phase 99mTc preloading strategy. J Nucl Med 48:1379\u20131389","journal-title":"J Nucl Med"},{"key":"535_CR20","volume-title":"Selected histochemical and histopathological methods","author":"SW Thompson","year":"1996","unstructured":"Thompson SW, Hunt RD (1996) Selected histochemical and histopathological methods. Charles C. Thomas, Springfield"},{"key":"535_CR21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/01.ATV.0000210016.89991.2a","volume":"26","author":"A Zaheer","year":"2006","unstructured":"Zaheer A, Murshed M, De Grand AM, Morgan TG, Karsenty G, Frangioni JV (2006) Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals. Arterioscler Thromb Vasc Biol 26:1132\u20131136","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"535_CR22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1515\/BC.2001.149","volume":"382","author":"P Knaus","year":"2001","unstructured":"Knaus P, Sebald W (2001) Cooperativity of binding epitopes and receptor chains in the BMP\/TGFbeta superfamily. Biol Chem 382:1189\u20131195","journal-title":"Biol Chem"},{"key":"535_CR23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.pep.2005.09.025","volume":"46","author":"S Long","year":"2006","unstructured":"Long S, Truong L, Bennett K, Phillips A, Wong-Staal F, Ma H (2006) Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli. Protein Expr Purif 46:374\u2013378","journal-title":"Protein Expr Purif"},{"key":"535_CR24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00432-008-0396-0","volume":"134","author":"S Steinert","year":"2008","unstructured":"Steinert S, Kroll TC, Taubert I, Pusch L, Hortschansky P, Hoffken K, Wolfl S, Clement JH (2008) Differential expression of cancer-related genes by single and permanent exposure to bone morphogenetic protein 2. J Cancer Res Clin Oncol 134:1237\u20131245","journal-title":"J Cancer Res Clin Oncol"},{"key":"535_CR25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10549-006-9362-1","volume":"103","author":"EL Alarmo","year":"2007","unstructured":"Alarmo EL, Kuukasjarvi T, Karhu R, Kallioniemi A (2007) A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 103:239\u2013246","journal-title":"Breast Cancer Res Treat"},{"key":"535_CR26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2106\/JBJS.H.00200","volume":"91","author":"JR Dimar 2nd","year":"2009","unstructured":"Dimar JR 2nd, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, Carreon LY (2009) Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am 91:1377\u20131386","journal-title":"J Bone Joint Surg Am"},{"key":"535_CR27","first-page":"401","volume":"27","author":"JH Clement","year":"2005","unstructured":"Clement JH, Raida M, Sanger J, Bicknell R, Liu J, Naumann A, Geyer A, Waldau A, Hortschansky P, Schmidt A et al (2005) Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol 27:401\u2013407","journal-title":"Int J Oncol"},{"key":"535_CR28","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/onc.2008.232","volume":"27","author":"Y Katsuno","year":"2008","unstructured":"Katsuno Y, Hanyu A, Kanda H, Ishikawa Y, Akiyama F, Iwase T, Ogata E, Ehata S, Miyazono K, Imamura T (2008) Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27:6322\u20136333","journal-title":"Oncogene"},{"key":"535_CR29","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/carcin\/bgg100","volume":"24","author":"EM Langenfeld","year":"2003","unstructured":"Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J (2003) The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24:1445\u20131454","journal-title":"Carcinogenesis"},{"key":"535_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1541-7786.141.2.3","volume":"2","author":"EM Langenfeld","year":"2004","unstructured":"Langenfeld EM, Langenfeld J (2004) Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2:141\u2013149","journal-title":"Mol Cancer Res"},{"key":"535_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jmbi.1999.2590","volume":"287","author":"C Scheufler","year":"1999","unstructured":"Scheufler C, Sebald W, Hulsmeyer M (1999) Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. J Mol Biol 287:103\u2013115","journal-title":"J Mol Biol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0535-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0535-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0535-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T16:00:31Z","timestamp":1685116831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0535-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,17]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0535-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,17]]}}}